17 results
424B3
SHPH
Shuttle Pharmaceuticals Holdings Inc
22 Mar 24
Prospectus supplement
6:07am
and provides the incentive to profit from its commercialization. Some of the SBIR’s program goals include stimulating technological innovation, meeting Federal … with the long-term interests of the Company’s stockholders;
review and approve corporate goals and objectives relating to chief executive officer
8-K
SHPH
Shuttle Pharmaceuticals Holdings Inc
30 Oct 23
Shuttle Pharma Advances Prostate Cancer Predictive Biomarker Program Through Exclusive License Agreement
5:14pm
fees, and certain milestone payments due upon the achievement of designated development goals, including initiating a validation clinical trial
424B3
SHPH
Shuttle Pharmaceuticals Holdings Inc
24 Aug 23
Prospectus supplement
2:00pm
potential and provides the incentive to profit from its commercialization. Some of the SBIR’s program goals include stimulating technological … the interests of key management with the long-term interests of the Company’s stockholders;
review and approve corporate goals and objectives relating
DRS
SHPH
Shuttle Pharmaceuticals Holdings Inc
29 Sep 22
Draft registration statement
12:00am
investigational new drug applications (INDs) for the extended Bio-availability Ropidoxuridine with the goals of initiating Phase I clinical trials in 2023 … to profit from its commercialization. Some of the SBIR’s program goals include stimulating technological innovation, meeting Federal research
424B4
b99c w9cj0y
31 Aug 22
Prospectus supplement with pricing info
6:16am
S-1/A
y02or73xsm3dyfxkno
23 Jun 22
IPO registration (amended)
5:24pm
S-1
966ft63co7up3h
3 Jun 22
IPO registration
5:32pm
S-1
EX-10.31
msbmun1h0rj
3 Jun 22
IPO registration
5:32pm
S-1
EX-10.2
cyywki
3 Jun 22
IPO registration
5:32pm
DRS/A
bza8xyfo02 bhfx1
26 Apr 22
Draft registration statement (amended)
12:00am
DRS
EX-10.2
2ak66id8g4545cw55m
16 Sep 19
Draft registration statement
12:00am
DRS
ts1hnnrgl2gdonhdjkv
16 Sep 19
Draft registration statement
12:00am
- Prev
- 1
- Next